Khashayar Shakiba, MD
Obstetrics & Gynecology · Paramus, NJNPI 1114121571
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,852 of the $8,878 with a category attached, or 77.2%. It is spread thinly across 36 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,006 and has fallen 87.8% since, to $367 in 2025. Among obstetrics & gynecology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 231 payments — averaging $38.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Momentis Surgical Inc.$1K
- Coloplast$1K
- Boston Scientific$836
- AbbVie$787
- Biotissue Holdings Inc.$641
- Astellas Pharma US Inc$616
- plus $4K from 30 others
What the payments were for
- Travel & lodging$1,50617%
- Food & beverage$6,85277%
- Education$4515%
- Gifts$691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Momentis Surgical Inc. | 4 | $1,223 |
| Coloplast | 17 | $1,173 |
| Boston Scientific | 5 | $836 |
| AbbVie(2 entities) | 46 | $787 |
| Biotissue Holdings Inc. | 7 | $641 |
| Astellas Pharma US Inc | 22 | $616 |
| Caldera Medical, Inc | 9 | $587 |
| Axonics, Inc. | 4 | $435 |
| Sumitomo Pharma America, Inc. | 14 | $431 |
| Millicent US Inc | 18 | $300 |
| Pfizer | 16 | $239 |
| Hologic Sales And Service, LLC | 2 | $206 |
| Myovant Sciences Inc. | 12 | $197 |
| Gynesonics, Inc. | 2 | $183 |
| Aspira Women's Health Inc | 1 | $135 |
| Therapeuticsmd, Inc. | 8 | $130 |
| Urovant Sciences Inc | 8 | $114 |
| Mayne Pharma Commercial LLC | 8 | $110 |
| Amgen | 4 | $58 |
| Mimedx Group, Inc. | 1 | $58 |
| Bluewind Medical | 2 | $57 |
| Aesculap, Inc. | 1 | $40 |
| AMAG Pharmaceuticals, Inc. | 3 | $40 |
| Hikma Pharmaceuticals USA | 2 | $38 |
| Bayer | 2 | $37 |
| Lupin Inc. | 2 | $28 |
| Merck | 2 | $27 |
| Johnson & Johnson | 1 | $21 |
| ABC Home Medical Supply, Inc. | 1 | $20 |
| Mycovia Pharmaceuticals, Inc. | 1 | $18 |
| Hollister Incorporated | 1 | $16 |
| Coopersurgical, Inc. | 1 | $16 |
| LSI Solutions Inc | 1 | $15 |
| Mission Pharmacal Company | 1 | $15 |
| Medtronic | 1 | $15 |
| Avion Pharmaceuticals | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Anovo Surgical System$1,223
- ALTIS$1,004
- SOLYX$584
- Desara$422
- Bulkamid$406
- FLUENT FLUID MANAGEMENT SYSTEM$150
- NovaSure$150
- ACESSA PROVU SYSTEM$150
- Axonics$137
- OVA1$135
- MYFEMBREE$124
- GEMTESA$120
- Orilissa$120
- GENERAL - THERAPIES$109
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM$107
- GENERAL FEMALE SUI$104
How this compares
$8,878 in reported general payments places this provider in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 89 | $84,921 |
| MyrbetriqMirabegron | 67 | $37,488 |
| IntrarosaPrasterone (Dhea) | 61 | $18,357 |
| PremarinEstrogens, Conjugated | 33 | $14,198 |
| EstringEstradiol | 25 | $12,642 |
| Estradiol | 84 | $5,444 |
| Methenamine Hippurate | 28 | $1,417 |
| Clobetasol Propionate | 13 | $436 |
| Hydroxyzine Pamoate | 69 | $353 |
| Hydroxyzine Hcl | 43 | $345 |
| Triamcinolone Acetonide | 26 | $219 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $186 |
| Gabapentin | 34 | $178 |
| Fluconazole | 14 | $106 |
| Ciprofloxacin Hcl | 14 | $55 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $431 | $84,92189 claims |
| Astellas Pharma US IncMyrbetriq | $616 | $37,48867 claims |
| PfizerPremarin, Estring | $239 | $26,84058 claims |
| AMAG Pharmaceuticals, Inc.Intrarosa | $40 | $18,35761 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Other obstetrics & gynecology in Paramus
- Cindy ParnesParamus$32K
- Craig WienerParamus$13K
- Jennifer AshtonEnglewood$1.5M
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Paula JasionowskiVoorhees$193K
- Justin ChuraSwedesboro$179K
- Andrea VentolaFlorham Park$145K
- Aiman ShiladPaterson$100K
- Patrick CulliganMorristown$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.